Rafii MS - Search Results

1

Alzheimer's disease associated with Down syndrome: a genetic form of dementia.

Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M. Fortea J, et al. Among authors: rafii ms. Lancet Neurol. 2021 Nov;20(11):930-942. doi: 10.1016/S1474-4422(21)00245-3. Lancet Neurol. 2021. PMID: 34687637 Free PMC article. Review.

2

Preclinical Alzheimer's disease therapeutics.

Rafii MS. Rafii MS. J Alzheimers Dis. 2014;42 Suppl 4:S545-9. doi: 10.3233/JAD-141482. J Alzheimers Dis. 2014. PMID: 25079804 Review.

3

Improving Memory and Cognition in Individuals with Down Syndrome.

Rafii MS. Rafii MS. CNS Drugs. 2016 Jul;30(7):567-73. doi: 10.1007/s40263-016-0353-4. CNS Drugs. 2016. PMID: 27272473 Review.

4

Targeting tau protein in Alzheimer's disease.

Rafii MS. Rafii MS. Lancet. 2016 Dec 10;388(10062):2842-2844. doi: 10.1016/S0140-6736(16)32107-9. Epub 2016 Nov 16. Lancet. 2016. PMID: 27863808 No abstract available.

5

A phase 3 trial of IV immunoglobulin for Alzheimer disease.

Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS; Alzheimer's Disease Cooperative Study. Relkin NR, et al. Among authors: rafii ms. Neurology. 2017 May 2;88(18):1768-1775. doi: 10.1212/WNL.0000000000003904. Epub 2017 Apr 5. Neurology. 2017. PMID: 28381506 Free PMC article. Clinical Trial.

6

Outcome Measures for Clinical Trials in Down Syndrome.

Esbensen AJ, Hooper SR, Fidler D, Hartley SL, Edgin J, d'Ardhuy XL, Capone G, Conners FA, Mervis CB, Abbeduto L, Rafii MS, Krinsky-McHale SJ, Urv T; Outcome Measures Working Group. Esbensen AJ, et al. Among authors: rafii ms. Am J Intellect Dev Disabil. 2017 May;122(3):247-281. doi: 10.1352/1944-7558-122.3.247. Am J Intellect Dev Disabil. 2017. PMID: 28452584 Free PMC article.

7

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.

Rafii MS, Skotko BG, McDonough ME, Pulsifer M, Evans C, Doran E, Muranevici G, Kesslak P, Abushakra S, Lott IT; ELND005-DS Study Group. Rafii MS, et al. J Alzheimers Dis. 2017;58(2):401-411. doi: 10.3233/JAD-160965. J Alzheimers Dis. 2017. PMID: 28453471 Free PMC article. Clinical Trial.

8

Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.

Carmona-Iragui M, Balasa M, Benejam B, Alcolea D, Fernández S, Videla L, Sala I, Sánchez-Saudinós MB, Morenas-Rodriguez E, Ribosa-Nogué R, Illán-Gala I, Gonzalez-Ortiz S, Clarimón J, Schmitt F, Powell DK, Bosch B, Lladó A, Rafii MS, Head E, Molinuevo JL, Blesa R, Videla S, Lleó A, Sánchez-Valle R, Fortea J. Carmona-Iragui M, et al. Among authors: rafii ms. Alzheimers Dement. 2017 Nov;13(11):1251-1260. doi: 10.1016/j.jalz.2017.03.007. Epub 2017 Apr 29. Alzheimers Dement. 2017. PMID: 28463681 Free PMC article.

9

Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.

Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, Siffert J, Aisen PS; AAV2-NGF Study Team. Rafii MS, et al. JAMA Neurol. 2018 Jul 1;75(7):834-841. doi: 10.1001/jamaneurol.2018.0233. JAMA Neurol. 2018. PMID: 29582053 Free PMC article. Clinical Trial.

10

Diagnostic biomarkers of Alzheimer's disease in Down syndrome.

Rafii MS. Rafii MS. Lancet Neurol. 2018 Oct;17(10):831-832. doi: 10.1016/S1474-4422(18)30293-X. Epub 2018 Aug 29. Lancet Neurol. 2018. PMID: 30172623 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page